- Helps in controlling blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of cardiovascular complications associated with diabetes.
- Improves glycemic control when used alongside diet and exercise.
- Facilitates weight loss in some patients due to increased glucose excretion.
- May help in preserving kidney function over time.
- Offers a dual mechanism of action for enhanced efficacy in managing diabetes.
- Convenient once-daily dosing improves patient adherence to treatment.
Empa Cad L 25 Tablet - Strip of 10
Compositions : Empagliflozin 25mg + Linagliptin 5mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Shrrishti Health Care Products Pvt Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Empa Cad L 25 Tablet is a pharmaceutical product designed to manage specific health conditions effectively. This medication is primarily composed of Empagliflozin and Linagliptin, which are active ingredients known for their roles in the treatment of type 2 diabetes mellitus. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion through urine. Linagliptin, on the other hand, is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the body's natural ability to lower blood sugar levels by increasing insulin release and decreasing glucagon levels in the bloodstream. The combination of these two agents in Empa Cad L 25 Tablet works synergistically to improve glycemic control in adults with type 2 diabetes. This medication is typically prescribed when diet and exercise alone do not provide adequate blood sugar control. It is essential for patients to understand the importance of adhering to prescribed dosages and maintaining regular follow-ups with healthcare providers to monitor their condition effectively. Empa Cad L 25 Tablet not only aids in managing blood glucose levels but also contributes to reducing the risk of cardiovascular events associated with diabetes, making it a vital component of comprehensive diabetes management.
Product Details
- Empagliflozin inhibits SGLT2, reducing glucose reabsorption in the kidneys.
- Increased glucose excretion leads to lower blood sugar levels.
- Linagliptin enhances insulin secretion in response to meals.
- It decreases glucagon secretion, which helps lower blood sugar levels.
- The combination of both agents provides a comprehensive approach to diabetes management.
- Take Empa Cad L 25 Tablet orally, with or without food.
- The usual recommended dosage is one tablet daily, as directed by your healthcare provider.
- It is advisable to take the tablet at the same time each day for consistency.
- Do not exceed the prescribed dosage; consult your doctor if you feel the need for adjustments.
- Continue taking the medication even if you feel well; diabetes requires ongoing management.
- If you miss a dose, take it as soon as you remember unless it's almost time for your next dose.
- Do not double up on doses to make up for a missed one.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly as advised by your healthcare provider.
- Stay hydrated and limit sugary beverages that can spike blood sugar levels.
- Avoid smoking and limit alcohol consumption, as these can affect diabetes management.
- Keep regular appointments with your healthcare team for ongoing assessment and support.
Safety Advice
Side Effects
- Common side effects may include:
- Urinary tract infections
- Genital fungal infections
- Nausea
- Diarrhea
- Serious side effects that require immediate medical attention:
- Severe allergic reactions (rash, itching, swelling)
- Ketoacidosis (symptoms include nausea, vomiting, abdominal pain)
- Kidney problems (reduced urine output)
Precautions and Warnings
- Do not use Empa Cad L 25 Tablet if you have a history of severe allergic reactions to its components.
- Caution is advised for patients with kidney or liver issues; consult your doctor before use.
- Avoid alcohol consumption while taking this medication as it may increase the risk of dehydration.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before starting treatment.
- Monitor blood sugar levels regularly and report any significant changes to your healthcare provider.
- Driving or operating heavy machinery may be affected; assess your response to the medication before engaging in such activities.
FAQs
Empa Cad L 25 Tablet may not be suitable for individuals with certain medical conditions. Always consult your healthcare provider before starting this medication.
2. What should I do if I miss a dose of Empa Cad L 25 Tablet?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose. Do not double up on doses.
3. Can I take Empa Cad L 25 Tablet with other medications?
Empa Cad L 25 Tablet may interact with other medications. Inform your doctor about all medications you are currently taking.
4. How should I store Empa Cad L 25 Tablet?
Store Empa Cad L 25 Tablet at room temperature, away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Empa Cad L 25 Tablet?
Common side effects may include urinary tract infections, genital infections, and dehydration. Contact your doctor if you experience severe side effects.
6. Can pregnant or breastfeeding women use Empa Cad L 25 Tablet?
Pregnant or breastfeeding women should consult their healthcare provider before using Empa Cad L 25 Tablet.
Instructions
No content available for this section.
More Information
| SKU | 623979 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Shrrishti Health Care Products Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Empa Cad L 25 Tablet is a pharmaceutical product designed to manage specific health conditions effectively. This medication is primarily composed of Empagliflozin and Linagliptin, which are active ingredients known for their roles in the treatment of type 2 diabetes mellitus. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion through urine. Linagliptin, on the other hand, is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the body's natural ability to lower blood sugar levels by increasing insulin release and decreasing glucagon levels in the bloodstream. The combination of these two agents in Empa Cad L 25 Tablet works synergistically to improve glycemic control in adults with type 2 diabetes. This medication is typically prescribed when diet and exercise alone do not provide adequate blood sugar control. It is essential for patients to understand the importance of adhering to prescribed dosages and maintaining regular follow-ups with healthcare providers to monitor their condition effectively. Empa Cad L 25 Tablet not only aids in managing blood glucose levels but also contributes to reducing the risk of cardiovascular events associated with diabetes, making it a vital component of comprehensive diabetes management.
- Helps in controlling blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of cardiovascular complications associated with diabetes.
- Improves glycemic control when used alongside diet and exercise.
- Facilitates weight loss in some patients due to increased glucose excretion.
- May help in preserving kidney function over time.
- Offers a dual mechanism of action for enhanced efficacy in managing diabetes.
- Convenient once-daily dosing improves patient adherence to treatment.
- Empagliflozin inhibits SGLT2, reducing glucose reabsorption in the kidneys.
- Increased glucose excretion leads to lower blood sugar levels.
- Linagliptin enhances insulin secretion in response to meals.
- It decreases glucagon secretion, which helps lower blood sugar levels.
- The combination of both agents provides a comprehensive approach to diabetes management.
- Take Empa Cad L 25 Tablet orally, with or without food.
- The usual recommended dosage is one tablet daily, as directed by your healthcare provider.
- It is advisable to take the tablet at the same time each day for consistency.
- Do not exceed the prescribed dosage; consult your doctor if you feel the need for adjustments.
- Continue taking the medication even if you feel well; diabetes requires ongoing management.
- If you miss a dose, take it as soon as you remember unless it's almost time for your next dose.
- Do not double up on doses to make up for a missed one.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly as advised by your healthcare provider.
- Stay hydrated and limit sugary beverages that can spike blood sugar levels.
- Avoid smoking and limit alcohol consumption, as these can affect diabetes management.
- Keep regular appointments with your healthcare team for ongoing assessment and support.
Side Effects
- Common side effects may include:
- Urinary tract infections
- Genital fungal infections
- Nausea
- Diarrhea
- Serious side effects that require immediate medical attention:
- Severe allergic reactions (rash, itching, swelling)
- Ketoacidosis (symptoms include nausea, vomiting, abdominal pain)
- Kidney problems (reduced urine output)
Precautions and Warnings
- Do not use Empa Cad L 25 Tablet if you have a history of severe allergic reactions to its components.
- Caution is advised for patients with kidney or liver issues; consult your doctor before use.
- Avoid alcohol consumption while taking this medication as it may increase the risk of dehydration.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before starting treatment.
- Monitor blood sugar levels regularly and report any significant changes to your healthcare provider.
- Driving or operating heavy machinery may be affected; assess your response to the medication before engaging in such activities.
Empa Cad L 25 Tablet may not be suitable for individuals with certain medical conditions. Always consult your healthcare provider before starting this medication.
2. What should I do if I miss a dose of Empa Cad L 25 Tablet?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose. Do not double up on doses.
3. Can I take Empa Cad L 25 Tablet with other medications?
Empa Cad L 25 Tablet may interact with other medications. Inform your doctor about all medications you are currently taking.
4. How should I store Empa Cad L 25 Tablet?
Store Empa Cad L 25 Tablet at room temperature, away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Empa Cad L 25 Tablet?
Common side effects may include urinary tract infections, genital infections, and dehydration. Contact your doctor if you experience severe side effects.
6. Can pregnant or breastfeeding women use Empa Cad L 25 Tablet?
Pregnant or breastfeeding women should consult their healthcare provider before using Empa Cad L 25 Tablet.
No content available for this section.
| SKU | 623979 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Shrrishti Health Care Products Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account